Article
High prevalence of hepatitis A in indigenous population on north Brazil
Registro en:
PAULA, Vanessa Salete de et al. High prevalence of hepatitis A in indigenous population in north Brazil. BMC Research Notes, v. 13, n. 458, p. 1-7, 2020.
1756-0500
10.1186/s13104-020-05303-y
Autor
Paula, Vanessa Salete de
Milagres, Flavio Augusto Pádua
Oliveira, Guilherme de Macêdo
Miguel, Juliana Custódio
Cruz, Helena Medina
Scaloni, Letícia de Paula
Maques, Vanessa Alves
Magalhães, Monica de Avelar Figueiredo Mafra
Romão, Anselmo Rocha
Gracie, Renata
Villar, Livia Melo
Resumen
Objectives: Little is known about hepatitis A virus (HAV) prevalence in indigenous communities. This study aims to evaluate the prevalence of HAV in indigenous community compared to urban population located at Western Amazon in Brazil. Results: A total of 872 serum samples were obtained from 491 indigenous and 381 non indigenous individuals aging 0 to 90 years. Samples were tested for total and IgM anti-HAV and positive IgM samples were tested for HAV RNA. The overall prevalence of total anti-HAV was 87%, increased according age showing 100% of prevalence in those aging more than 30 years (p<0.0001) and it was similar among indigenous and urban population. Total anti-HAV prevalence varied between tribes (p<0.0001) and urban sites (p=0.0014) and spatial distribution showed high prevalence in homes that received up to 100 dollars. IgM anti-HAV prevalence was 1.7% with predominance in males, those aging more than 41 years. No HAV RNA was detected. In conclusion, high overall anti-HAV prevalence was found in indigenous communities in North Brazil demonstrating the importance of universal vaccination in this group.